Epidemiology and Outcome of Patients With Burns Treated With Cerium Nitrate Silversulfadiazine
Autor: | J. Hiddingh, Anuschka S. Niemeijer, Magriet E. van Baar, S.M.H.J. Scholten-Jaegers, Marianne K. Nieuwenhuis, G.I.J.M. Beerthuizen |
---|---|
Přispěvatelé: | Functional recovery and quality of life after burns |
Rok vydání: | 2016 |
Předmět: |
Male
therapeutisch gebruik Burn Units 030207 dermatology & venereal diseases 0302 clinical medicine Epidemiology Child Netherlands Aged 80 and over Mortality rate Rehabilitation Cerium brandwondencentra Middle Aged Silver Sulfadiazine Thermal burn drug therapy zilversulfadiazine Conservative treatment Survival Rate Drug Combinations Treatment Outcome gender differences Child Preschool Flammacerium Emergency Medicine Nederland Female anti-infectieuze middelen geneesmiddelentherapie Burns Adult medicine.medical_specialty behandelingsresultaat Adolescent leeftijdsgroepen retrospectieve studies 03 medical and health sciences Young Adult medicine Humans Severe burn Aged Retrospective Studies brandwonden business.industry Infant Newborn Infant 030208 emergency & critical care medicine Retrospective cohort study overlevingskansen age groups Length of Stay medicijncombinaties Surgery Outcome parameter lenght of stay verblijfsduur geslachtsverschillen therapeutic use Anti-Infective Agents Local anti-infective agents silver sulfadiazin business |
Zdroj: | Journal of burn care & research : official publication of the American Burn Association, 38(1), e432-e442. Lippincott, Williams & Wilkins |
ISSN: | 1559-0488 1559-047X |
Popis: | In this study, the outcome of treatment with Flammacerium in burn patients is studied. The retrospective study involved patients with acute burns admitted to the Burn Centre of Martini Hospital, Groningen, The Netherlands, between 2009 and 2014. The outcome parameters were mortality, complications (noninfectious and infectious), need of surgery, and length of stay. The group of patients consisted of 853 patients, of which 554 were male (64.9%). There were 23 patients with a total burn size of 40% TBSA or more (2.7%). In total, 13 of the 853 patients (1.5%) died, and none of them were children (40% TBSA was 30.4%. In the elderly group (>70 years), the mortality rate was 6.3%. Treatment with Flammacerium is applicable in all thermal burn patients. Especially children, elderly patients, and patients with severe burns can benefit from a more conservative treatment with Flammacerium whereby the first operation can be postponed until the patient is stabilized and in which the wounds can be covered directly with skin transplants. |
Databáze: | OpenAIRE |
Externí odkaz: |